Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc (DNA) Option Chain
As of September 18, 2026, Ginkgo Bioworks Holdings Inc is trading at $7.88, a +0.51% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 89.1%. IV Rank is 13%.
Read more
Tracking the DNA option chain helps you see every strike and expiry on Ginkgo Bioworks Holdings Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Ginkgo Bioworks Holdings Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DNA options activity at a glance. Use our scanner to monitor the DNA option chain in real time and filter for the DNA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DNA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the DNA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where DNA stock options are being actively traded and where they are not.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Ginkgo Bioworks Holdings Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen DNA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of DNA stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile25.40% Subdued
- Market cap (M$)531
- 52 weeks high-55.18%
- 52 weeks low46.74%
- Analyst recommendationSell
4.33 - Target price$7.00
-11.17% below the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-5.44
- EPS growth next 5 years—
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| Loading option chain… | |||||||||||||||
As of September 18, 2026
Scan the full option chain in one place
Browse the full DNA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→